Enovis Corp
Company Profile
Business description
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Contact
2711 Centerville Road
Suite 400
WilmingtonDE19808
USAT: +1 302 252-9160
E: investorrelations@enovis.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
7,367
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 7,959.70 | 106.00 | 1.35% |
CAC 40 | 7,277.89 | 173.09 | 2.44% |
DAX 40 | 20,926.08 | 551.98 | 2.71% |
Dow JONES (US) | 40,212.71 | 619.05 | 1.56% |
FTSE 100 | 8,123.64 | 159.46 | 2.00% |
HKSE | 21,417.40 | 502.71 | 2.40% |
NASDAQ | 16,724.46 | 337.14 | 2.06% |
Nikkei 225 | 33,982.36 | 396.78 | 1.18% |
NZX 50 Index | 12,107.54 | 88.41 | 0.74% |
S&P 500 | 5,363.36 | 0.00 | 0.00% |
S&P/ASX 200 | 7,748.60 | 102.10 | 1.34% |
SSE Composite Index | 3,262.81 | 24.58 | 0.76% |